Role of calprotectin in cardiometabolic diseases

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

KRUŽLIAK Peter NOVÁK Jan NOVÁK Miroslav FODOR George J.

Year of publication 2014
Type Article in Periodical
Magazine / Source Cytokine & Growth Factor Reviews
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.sciencedirect.com/science/article/pii/S1359610114000069
Doi http://dx.doi.org/10.1016/j.cytogfr.2014.01.005
Field Physiology
Keywords Calprotectin; Cardiovascular diseases; Metabolic diseases; Obesity; Myocardial infarction
Description Calprotectin represents an interesting peptide known to be involved in the pathophysiology of various inflammatory processes. Being secreted from activated neutrophils and monocytes under various conditions, it can also be found in the extracellular fluids and serve as a biomarker of ongoing inflammation, which property is currently used in the monitoring of inflammatory bowel diseases. Recent studies, however, suggest that calprotectin could serve as an important prognostic factor for cardiovascular and cardiometabolic diseases, since these are occurring on the basis of low-grade chronic inflammation. We assume that calprotectin may represent a useful marker in predicting the course of atherosclerotic process, coronary artery disease and acute coronary syndromes. Our review is focused on the importance of calprotectin in the diagnosis and prognostic stratification in the field of cardiometabolic risk.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.